LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis

Related Experiment Video

Updated: Nov 21, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K

Aleksandra Gąsecka1, Sylwester Rogula1, Łukasz Szarpak2,3

  • 1Department of Cardiology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Life (Basel, Switzerland)
|January 14, 2021
PubMed

Insights

Oxidized low-density lipoproteins (ox-LDL) directly interact with platelets, promoting thrombus formation and contributing to atherosclerosis. Understanding these interactions may lead to new prevention strategies.

Area of Science:

  • Cardiovascular Research
  • Hematology
  • Lipid Metabolism

Background:

  • Atherosclerosis is a leading cause of global mortality.
  • Key mechanisms include platelet activation and elevated low-density lipoprotein (LDL) levels.
  • Oxidized LDL (ox-LDL) exhibits pro-thrombotic properties, unlike native LDL.

Purpose of the Study:

  • To review evidence on LDL-cholesterol and platelet interactions in atherosclerosis.
  • To explore the clinical implications and therapeutic potential of these interactions.

Main Methods:

  • Literature review summarizing current evidence.
  • Focus on ox-LDL binding sites on platelets.
  • Examination of ox-LDL generation by platelets.
  • Analysis of the roles of activated platelets and ox-LDL in atherogenesis.

Main Results:

  • Platelets possess binding sites for ox-LDL.
  • Platelets can generate ox-LDL.
  • Activated platelets and ox-LDL synergistically promote thrombus formation and atherosclerosis.

Conclusions:

  • Interactions between LDL-cholesterol and platelets are critical in atherosclerosis.
  • Modulating these interactions offers potential for novel therapeutic strategies.
  • Understanding platelet-ox-LDL pathways is key for atherosclerosis prevention.

Keywords:
LDL-cholesterolatherosclerosisextracellular vesiclesplateletstreatment

More Related Videos

Quantification of Atherosclerosis in Mice06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

39.4K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.8K

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
389
Inflammation01:38

Inflammation

Overview
57.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
188
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
131
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
865